Clinical study of drug-coated balloon with Paclitaxel for treatment of coronary in-stent restenosis
LIANG Ying1 HUANG Hanhui1 LAI Tianxing1 ZOU Duan1 LIN Caiyan1 CHEN Ximing2 YAN Pengke1▲
1.Department of Pharmacy, the Third Affiliated Hospital of Guangzhou Medical University, Guangdong Province, Guangzhou 510150, China;
2.Department of Cardiovascular Medicine, the Third Affiliated Hospital of Guangzhou Medical University, Guangdong Province, Guangzhou 510150, China
Abstract:Objective To explore the clinical efficacy of drug-coated balloon with Paclitaxel for treatment of coronary in-stent restenosis. Methods Eighty-seven patients with coronary in-stent restenosis admitted to the Third Affiliated Hospital of Guangzhou Medical University from January 2015 to December 2016 was divided into control group (43 cases) and treatment group (44 cases) by random number table method. Control group was treated with drug-eluting stent, while treatment group was treated with drug-coated balloon with Paclitaxel. The rate of cardiovascular adverse events after operation for 1, 6, 12 months and the incidence of coronary in-stent restenosis after operation for 12 months of the two groups were observed and compared. Results The total rate of cardiovascular adverse events and the incidence of coronary in-stent restenosis of treatment group (6.82%, 6.82%) were both lower than those of control group (23.26%, 27.91%) after operation for 12 months, the differences were statistically significant (χ2=4.623, P = 0.032; χ2=6.778, P = 0.009). Conclusion The drug-coated balloon with Paclitaxel is effective in the treatment of coronary in-stent restenosis, it can reduce the incidence of cardiovascular adverse events and avoid placing stents again, it is worthy of promotion and application in clinic.
梁颖1 黄汉辉1 赖天幸1 邹端1 林彩燕1 陈晞明2 严鹏科1▲. 紫杉醇药物涂层球囊治疗冠脉支架内再狭窄的临床研究[J]. 中国医药导报, 2018, 15(26): 43-45.
LIANG Ying1 HUANG Hanhui1 LAI Tianxing1 ZOU Duan1 LIN Caiyan1 CHEN Ximing2 YAN Pengke1▲. Clinical study of drug-coated balloon with Paclitaxel for treatment of coronary in-stent restenosis. 中国医药导报, 2018, 15(26): 43-45.